相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名:
KPT-9274
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
1643913-93-2
- 规格:
10 mM * 1 mL/1 mg/5 mg/10 mg/25 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥2418.0 |
|---|---|---|---|
| 规格: | 1 mg | 产品价格: | ¥700.0 |
| 规格: | 5 mg | 产品价格: | ¥1800.0 |
| 规格: | 10 mg | 产品价格: | ¥2900.0 |
| 规格: | 25 mg | 产品价格: | ¥4800.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Padnarsertib
CAS No. : 1643913-93-2
MCE 国际站:Padnarsertib
产品活性:Padnarsertib (KPT-9274) 是口服有效的 PAK4/烟酰胺磷酸核糖基转移酶 (Nampt) 抑制剂,IC50 分别 <100 和 125 nM。
研究领域:Cell Cycle/DNA Damage | Cytoskeleton | Metabolic Enzyme/Protease
In Vitro: Padnarsertib attenuates the PAK4/β-catenin pathway, results in NAD depletion, and attenuates viability, invasion, and migration in several RCC cell lines. Inhibition of NAMPT in a cell-free enzymatic assay using recombinant NAMPT shows an IC50 of approximately 120 nM for Padnarsertib. Padnarsertib attenuates G2–M transit and induces apoptosis in RCC cell lines.
In Vivo: Padnarsertib demonstrates a decrement of xenograft growth comparable with that of Sunitinib (HY-10255A). There are minimal Padnarsertib effects on the normal human RPTECs and no apparent toxicity in vivo.
Padnarsertib is currently being investigated in a phase I human clinical trial of patients with advanced solid malignancies and NHL.
Padnarsertib (oral administation; 100mg/kg or 200 mg/kg; twice a day; 14 days) demonstrates a decrement of xenograft growth without no significant weight loss. 8 hours after, Padnarsertib are measured at the end of the experiment in mouse plasma and tumors with 10757 ng/mL and 10647 ng/mL, respectively.
相关产品:Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | Cell Cycle/DNA Damage Compound Library | Kinase Inhibitor Library | Metabolism/Protease Compound Library | Anti-Cancer Compound Library | Clinical Compound Library | Anti-Aging Compound Library | Drug Repurposing Compound Library | Cytoskeleton Compound Library | Orally Active Compound Library | Targeted Diversity Library | Membrane Protein-targeted Compound Library | Highly Selective Inhibitors Library | (E)-Daporinad | Fingolimod hydrochloride | 5-Aminosalicylic Acid | PF-3758309 | IPA-3 | NVS-PAK1-1 | FRAX597 | SBI-797812 | FRAX486 | CHS-828 | G-5555 | OT-82 | NAT | GNE 2861 | GNE-617 | Nampt-IN-1 | FRAX1036 | GNE-618 | LCH-7749944 | STF-118804 | MRIA9 | Teglarinad chloride | AZ13705339 hemihydrate | GPP78 | Nampt activator-1 | Nampt activator-2 | Nampt activator-3
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料

















